Letter to the EditorFull Access
Published Online:1 Nov 2004https://doi.org/10.1176/appi.ajp.161.11.2132
- Cited by
- 11 April 2018 | Journal of Autism and Developmental Disorders, Vol. 48, No. 9
- Annual Review of Pharmacology and Toxicology, Vol. 58, No. 1
- 14 February 2017 | Drugs, Vol. 77, No. 4
- 8 December 2013 | Journal of Neural Transmission, Vol. 121, No. 8
- Annual Review of Pharmacology and Toxicology, Vol. 54, No. 1
- Journal of Psychiatric Research, Vol. 47, No. 7
- 1 September 2012 | International Journal of Neuropsychopharmacology, Vol. 15, No. 8
- 13 February 2012 | Bipolar Disorders, Vol. 14, No. 1
- Biological Psychiatry, Vol. 68, No. 9
- The Journal of ECT, Vol. 26, No. 3
- Hippocampal N-Acetylaspartate Concentration and Response to Riluzole in Generalized Anxiety DisorderBiological Psychiatry, Vol. 63, No. 9
- Biological Psychiatry, Vol. 62, No. 11
- 24 April 2007 | Molecular Psychiatry, Vol. 12, No. 11
- 12 December 2006 | European Journal of Neuroscience, Vol. 24, No. 12
- Journal of Clinical Psychopharmacology, Vol. 26, No. 2
- Sanjay J. Mathew,
M.D. , - Jonathan M. Amiel,
B.S. , - Jeremy D. Coplan,
M.D. , - Heidi A. Fitterling,
B.A. , - Harold A. Sackeim,
Ph.D. , and - Jack M. Gorman,
M.D.
1 December 2005 | American Journal of Psychiatry, Vol. 162, No. 12- Sanjay J. Mathew,